Long-term mortality and quality of life after septic shock: a follow-up observational study

PurposeIn septic shock, short-term outcomes are frequently reported, while long-term outcomes are not. The aim of this study was to evaluate mortality and health-related quality of life (HRQOL) in survivors 6 months after an episode of septic shock.MethodsThis single-centre observational study was conducted in an intensive care unit in a university hospital. All patients with septic shock were included. Mortality was assessed 6 months after the onset of septic shock, and a comparison between patients who survived and those who died was performed. HRQOL was assessed using the MOS SF-36 questionnaire prior to hospital admission (baseline) and at 6 months in survivors. HRQOL at baseline and at 6 months were compared to the general French population, and HRQOL at baseline was compared to 6-month HRQOL.ResultsNinety-six patients were included. Six-month mortality was 45 %. Survivors were significantly younger, had significantly lower lactate levels and SAPS II scores, required less renal support, received less frequent administration of corticosteroids, and had a longer length of hospital stay. At baseline (n = 39) and 6 months (n = 46), all of the components of the SF-36 questionnaire were significantly lower than those in the general population. Compared to baseline (n = 23), the Physical Component Score (CS) improved significantly at 6 months, the Mental CS did not differ.ConclusionsMortality 6 months after septic shock was high. HRQOL at baseline was impaired when compared to that of the general population. Although improvements were noted at 6 months, HRQOL remained lower than that in the general population.

[1]  Peter J. Pronovost,et al.  Quality of life in adult survivors of critical illness: A systematic review of the literature , 2005, Intensive Care Medicine.

[2]  Javier Llorca,et al.  Impact of the Surviving Sepsis Campaign protocols on hospital length of stay and mortality in septic shock patients: Results of a three-year follow-up quasi-experimental study* , 2010, Critical care medicine.

[3]  C. Sprung,et al.  The ACCP-SCCM consensus conference on sepsis and organ failure. , 1992, Chest.

[4]  T. Perneger,et al.  The French SF-36 Health Survey: translation, cultural adaptation and preliminary psychometric evaluation. , 1998, Journal of clinical epidemiology.

[5]  A. Schrijvers,et al.  Quality of life on admission to the intensive care: can we query the relatives? , 2003, Intensive Care Medicine.

[6]  D. Turnbull,et al.  Mitochondrial DNA and survival after sepsis: a prospective study , 2005, The Lancet.

[7]  J. Vincent.  Endpoints in sepsis trials: More than just 28-day mortality? , 2004, Critical care medicine.

[8]  P. Pronovost,et al.  Long-term mortality and quality of life in sepsis: A systematic review* , 2010, Critical care medicine.

[9]  C. Brun-Buisson,et al.  EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units , 2004, Intensive Care Medicine.

[10]  H. V. van Stel,et al.  The Impact of Severe Sepsis on Health-Related Quality of Life: A Long-Term Follow-Up Study , 2008, Anesthesia and analgesia.

[11]  S. Lemeshow,et al.  A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. , 1993, JAMA.

[12]  E. Ruokonen,et al.  Long-term outcome and quality-adjusted life years after severe sepsis* , 2009, Critical care medicine.

[13]  S. Ridley,et al.  Changes in quality of life after intensive care: comparison with normal data , 1997, Anaesthesia.

[14]  A Coulter,et al.  Short form 36 (SF36) health survey questionnaire: normative data for adults of working age. , 1993, BMJ.

[15]  S. Ridley,et al.  Quality of life after intensive care , 1990, Anaesthesia.

[16]  D. Heyland,et al.  Long-term health-related quality of life in survivors of sepsis. Short Form 36: A valid and reliable measure of health-related quality of life , 2000, Critical care medicine.

[17]  S. Ridley,et al.  Short Form 36 in the intensive care unit: assessment of acceptability, reliability and validity of the questionnaire , 1997, Anaesthesia.

[18]  Corinne Alberti,et al.  Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study , 2002, Intensive Care Medicine.

[19]  R. Wenzel,et al.  Long-Term Survival and Function After Suspected Gram-Negative Sepsis , 1996 .

[20]  S. Bagshaw,et al.  One-year mortality of bloodstream infection-associated sepsis and septic shock among patients presenting to a regional critical care system , 2005, Intensive Care Medicine.

[21]  Epidemiology of sepsis syndrome in 8 academic medical centers. , 1997 .

[22]  Amber E Barnato,et al.  Use of intensive care at the end of life in the United States: An epidemiologic study* , 2004, Critical care medicine.

[23]  Luke Vale,et al.  Quality of life in the five years after intensive care: a cohort study , 2010, Critical care.

[24]  C. Natanson,et al.  Bundled care for septic shock: An analysis of clinical trials* , 2010, Critical care medicine.

[25]  H. V. van Stel,et al.  Quality of life before intensive care unit admission is a predictor of survival , 2007, Critical care.

[26]  A. Riedel,et al.  Severe Sepsis in Managed Care: Analysis of Incidence, One-Year Mortality, and Associated Costs of Care , 2004, Journal of managed care pharmacy : JMCP.

[27]  J. E. Brazier,et al.  Validating the SF-36 health survey questionnaire: new outcome measure for primary care. , 1992, BMJ.

[28]  D. Angus,et al.  Surviving Intensive Care: a report from the 2002 Brussels Roundtable , 2003, Intensive Care Medicine.

[29]  M. Levy,et al.  Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. , 2008, JAMA.

[30]  K. Weinfurt,et al.  The correlation between patient characteristics and expectations of benefit from Phase I clinical trials , 2003, Cancer.

[31]  Epidemiology of sepsis syndrome in 8 academic medical centers. , 1998, JAMA.

[32]  Andrew Rhodes,et al.  Drotrecogin alfa (activated) in adults with septic shock. , 2012, The New England journal of medicine.

[33]  E Peterson,et al.  Early goal-directed therapy in the treatment of severe sepsis and septic shock. , 2018, The New England journal of medicine.

[34]  M. Capuzzo,et al.  Quality of life before intensive care admission: agreement between patient and relative assessment , 2000, Intensive Care Medicine.

[35]  A. Costa-Pereira,et al.  Quality of life of survivors from severe sepsis and septic shock may be similar to that of others who survive critical illness , 2004, Critical care.

[36]  C. Sprung,et al.  Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. , 1998, Critical care medicine.

[37]  Sangeeta Mehta,et al.  Vasopressin versus norepinephrine infusion in patients with septic shock. , 2008, The New England journal of medicine.

[38]  T. Stijnen,et al.  Review: a gentle introduction to imputation of missing values. , 2006, Journal of clinical epidemiology.

[39]  U. Janssens,et al.  Health-related quality of life before, 1 month after, and 9 months after intensive care in medical cardiovascular and pulmonary patients , 2003, Critical care medicine.

[40]  D. Annane,et al.  Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial , 2007, The Lancet.

[41]  M. Kenward,et al.  Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls , 2009, BMJ : British Medical Journal.

[42]  E. Hahn,et al.  Health-related quality of life of patients with multiple organ dysfunction: Individual changes and comparison with normative population , 2003, Critical care medicine.

[43]  E. Ivers,et al.  Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock , 2001 .

[44]  E. Hahn,et al.  Changes in quality of life after medical intensive care , 2001, Intensive Care Medicine.

[45]  G. Bernard,et al.  The effect of drotrecogin alfa (activated) on long-term survival after severe sepsis * , 2004, Critical care medicine.